全聚德(002186.SZ):2022下半年拓寬產品線,採取委託加工方式新推出兩款全聚德定製醬香型白酒
格隆匯4月28日丨有投資者在投資者互動平台向全聚德(002186.SZ)提問,“之前周總接受媒體採訪説,春節後第二批定製酒上市,請問何時上市?或門店已經開始銷售第二批定製酒了?”
全聚德回覆稱,公司在2022下半年拓寬產品線,採取委託加工方式新推出兩款全聚德定製醬香型白酒,年底在全聚德天貓旗艦店等線上平台及京內京外各家門店上市銷售,消費者反饋良好,公司會根據銷售情況安排制定銷售計劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.